News

Jun 24
Press release on the reopening of trading in Elia Group

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Elia Group, ISIN BE0003822393, on Euronext Brussels will re-open on 24/06/2022 at 16:30 CET. Source: FSMA

Jun 24
Agreed settlements relating to individual pension commitments

This press release is not available in English. Please consult the French or Dutch page. Source: FSMA

Jun 24
Restrictions placed on Colbourne & Company

On 23 June 2022 the FCA imposed a number of restrictions on Colbourne & Company stopping it from carrying out any regulated activities due to concerns about the way it conducts its business. We consider that Colbourne & Company, a small IFA, has for a number of years been carrying out regulated activities outside it’s […]

Jun 24
Supreme Court overturns Roe v. Wade

The U.S. Supreme Court has overturned Roe v. Wade, its landmark 1973 decision that established a constitutional right to an abortion. The high court had been expected to overturn the precedent after a May 2 report by Politico citing a leaked draft majority opinion of the pending ruling. Source: Marketwatch

Jun 24
Aurora Cannabis upgraded to overweight on prospects for European business

Aurora Cannabis ACB, +10.08% ACB, +8.82% rallied 6% in premarket trades on Friday after Cantor Fitzgerald analyst Pablo Zuanic upgraded the Canadian cannabis company to overweight from neutral and raised his 12-month price target on the stock to C$4.05 ($3.12) from C$3.90. Zuanic said Aurora Cannabis could benefit from growth in the legal cannabis market […]

Jun 24
Emergent BioSolutions says FDA has accepted its anthrax vaccine candidate for review

Emergent BioSolutions Inc. EBS, +7.19% said Friday the U.S. Food and Drug Administration has accepted for review its application for approval of its anthrax vaccine. Dubbed AV7909, the vaccine is aimed at people aged 18 through 65 years who have been exposed to anthrax for use along with recommended antibacterial drugs. A decision is expected […]